Advanced search
Publication Cover
Cancer Biology & Therapy Volume 22, 2021 - Issue 3
Submit an article Journal homepage
1,408
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model

Christopher W. Schultza Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0001-5731-2847View further author information
ORCID Icon,
Gorka Ruiz de Garibayb Department of Clinical Medicine, University of Bergen, Bergen, NorwayView further author information
,
Anika Langerb Department of Clinical Medicine, University of Bergen, Bergen, NorwayView further author information
,
Ji-Bin Liua Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Teena Dhira Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Calum Leitchb Department of Clinical Medicine, University of Bergen, Bergen, NorwayView further author information
,
Corinne E. Wessnera Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Mireia Mayoralb Department of Clinical Medicine, University of Bergen, Bergen, NorwayView further author information
,
Bo Zhangc Department of Ultrasound, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaView further author information
,
Mihaela Popab Department of Clinical Medicine, University of Bergen, Bergen, NorwayView further author information
,
Chunwang Huangd Department of Echocardiography, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, ChinaView further author information
,
Spiros Kotopoulisb Department of Clinical Medicine, University of Bergen, Bergen, Norway;e Department of Ultrasound, National Center for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, NorwayView further author information
,
Xianghong Luof Shanghai General Hospital, Shanghai, ChinaView further author information
,
Yanhua Zheng Department of Ultrasound, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Sihua Niuh Department of Ultrasound, Peking University People’s Hospital, Beijing, ChinaView further author information
,
Mehnoosh Torkzabana Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Kirk Wallacei GE Global Research, Niskayuna, NY, USAView further author information
,
John R. Eisenbreya Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Jonathan R. Brodya Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Emmet McCormackb Department of Clinical Medicine, University of Bergen, Bergen, NorwayView further author information
&
Flemming Forsberga Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2215-1371View further author information
ORCID Icon show all
Pages 204-215 | Received 09 May 2020, Accepted 19 Jan 2021, Published online: 10 Mar 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. Epub 2018/ 01/10. doi: 10.3322/caac.21442. PubMed PMID: 29313949.
  • Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the national cancer database. Cancer. 2007;110(4):738–744. Epub 2007 June 21. doi: 10.1002/cncr.22852. PubMed PMID: 17580363.
  • Hegewisch-Becker S, Aldaoud A, Wolf T, Krammer-Steiner B, Linde H, Scheiner-Sparna R, Hamm D, Janicke M, Marschner N, TP KG, et al. Results from the prospective German TPK clinical cohort study: treatment algorithms and survival of 1,174 patients with locally advanced, inoperable or metastatic pancreatic ductal adenocarcinoma. Int J Cancer. 2018;144(5):981–990. Epub 2018/ 07/15. doi: 10.1002/ijc.31751. PubMed PMID: 30006989.
  • Kowalewski A, Szylberg L, Saganek M, Napiontek W, Antosik P, Grzanka D. Emerging strategies in BRCA-positive pancreatic cancer. J Cancer Res Clin Oncol. 2018;144(8):1503–1507. Epub 2018/ 05/20. doi: 10.1007/s00432-018-2666-9. PubMed PMID: 29777302.
  • Jin WH, Hoffe SE, Shridhar R, Strom T, Venkat P, Springett GM, Hodul PJ, Pimiento JM, Meredith KL, Malafa MP, et al. Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail. J Gastrointest Oncol. 2018;9(3):487–494. Epub 2018/ 07/13. doi: 10.21037/jgo.2018.02.02. PubMed PMID: 29998014; PMCID: PMC6006031.
  • Abrams RA. Role of radiation therapy in the management of the patient with pancreatic cancer. Oncology (Williston Park). 1996;10(9 Suppl):13–17. Epub 1996/ 09/01. PubMed PMID: 8884802.
  • Kayahara M, Funaki K, Tajima H, Takamura H, Ninomiya I, Kitagawa H, Ohta T. Surgical implication of micrometastasis for pancreatic cancer. Pancreas. 2010;39(6):884–888. Epub 2010/ 02/26. doi: 10.1097/MPA.0b013e3181ce6daa. PubMed PMID: 20182392.
  • Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324(5933):1457–1461. Epub 2009/ 05/23. doi: 10.1126/science.1171362. PubMed PMID: 19460966; PMCID: PMC2998180.
  • Xie D, Xie K. Pancreatic cancer stromal biology and therapy. Genes Dis. 2015;2(2):133–143. Epub 2015/ 06/27. doi: 10.1016/j.gendis.2015.01.002. PubMed PMID: 26114155; PMCID: PMC4476547.
  • Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000;48(4):919–922. Epub 2000/ 11/10. doi: 10.1016/s0360-3016(00)00803-8. PubMed PMID: 11072146.
  • Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, Vander Heiden MG, Miller G, Drebin JA, Bar-Sagi D, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75(3):544–553. Epub 2015/ 02/04. doi: 10.1158/0008-5472.CAN-14-2211. PubMed PMID: 25644265; PMCID: PMC4316379.
  • Catenacci DV, Junttila MR, Karrison T, Bahary N, Horiba MN, Nattam SR, Marsh R, Wallace J, Kozloff M, Rajdev L, et al. Randomized phase Ib/II study of Gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer. J Clin Oncol. 2015;33(36):4284–4292. Epub 2015/ 11/04. doi: 10.1200/JCO.2015.62.8719. PubMed PMID: 26527777; PMCID: PMC4678179.
  • Ramanathan RK, McDonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, Thumar J, Chiorean EG, Shields AF, Behl D, et al. Phase IB/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313. J Clin Oncol. 2019;37(13):1062–1069. Epub 2019/ 03/01. doi: 10.1200/JCO.18.01295. PubMed PMID: 30817250; PMCID: PMC6494359.
  • 1Hingorani SR, Zheng L, Bullock AJ, Seery TE, Harris WP, Sigal DS, Braiteh F, Ritch PS, Zalupski MM, Bahary N, et al. HALO 202: randomized Phase II Study of PEGPH20 plus nab-paclitaxel/gemcitabine versus nab-paclitaxel/gemcitabine in patients with untreated, metastatic pancreatic ductal adenocarcinoma. J Clin Oncol. 2018;36(4):359–366. Epub 2017/ 12/13. doi: 10.1200/JCO.2017.74.9564. PubMed PMID: 29232172.
  • Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418–429. Epub 2012/ 03/24. doi: 10.1016/j.ccr.2012.01.007. PubMed PMID: 22439937; PMCID: PMC3371414.
  • Helfield B, Chen X, Watkins SC, Villanueva FS. Biophysical insight into mechanisms of sonoporation. Proc Natl Acad Sci U S A. 2016;113(36):9983–9988. Epub 2016/ 08/24. doi: 10.1073/pnas.1606915113. PubMed PMID: 27551081; PMCID: PMC5018802.
  • Kooiman K, Roovers S, Langeveld SAG, Kleven RT, Dewitte H, O’Reilly MA, Escoffre JM, Bouakaz A, Verweij MD, Hynynen K, et al. Ultrasound-responsive cavitation nuclei for therapy and drug Delivery. Ultrasound Med Biol. 2020;46(6):1296–1325. Epub 2020/ 03/14. doi: 10.1016/j.ultrasmedbio.2020.01.002. PubMed PMID: 32165014; PMCID: PMC7189181.
  • Bouakaz A, de Jong N. WFUMB safety symposium on echo-contrast agents: nature and types of ultrasound contrast agents. Ultrasound Med Biol. 2007;33(2):187–196. Epub 2007/ 01/16. doi: 10.1016/j.ultrasmedbio.2006.07.008. PubMed PMID: 17223253.
  • Lyshchik A. Specialty Imaging: fundamentals of CEUS. Amsterdam, The Netherlands: Elsevier; 2019.
  • Bjanes T, Kotopoulis S, Murvold ET, Kamceva T, Gjertsen BT, Gilja OH, Schjott J, Riedel B, McCormack E. Ultrasound- and microbubble-assisted gemcitabine delivery to pancreatic cancer cells. Pharmaceutics. 2020;12(2):141. Epub 2020/ 02/13. doi: 10.3390/pharmaceutics12020141. PubMed PMID: 32046005; PMCID: PMC7076495
  • Bressand D, Novell A, Girault A, Raoul W, Fromont-Hankard G, Escoffre JM, Lecomte T, Bouakaz A. Enhancing Nab-Paclitaxel delivery using microbubble-assisted ultrasound in a pancreatic cancer model. Mol Pharm. 2019;16(9):3814–3822. Epub 2019/ 07/30. doi: 10.1021/acs.molpharmaceut.9b00416. PubMed PMID: 31356090.
  • Kotopoulis S, Delalande A, Popa M, Mamaeva V, Dimcevski G, Gilja OH, Postema M, Gjertsen BT, McCormack E. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Mol Imaging Biol. 2014;16(1):53–62. Epub 2013/ 07/24. doi: 10.1007/s11307-013-0672-5. PubMed PMID: 23877869.
  • Dimcevski G, Kotopoulis S, Bjanes T, Hoem D, Schjott J, Gjertsen BT, Biermann M, Molven A, Sorbye H, McCormack E, et al. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J Control Release. 2016;243:172–181. Epub 2016/ 11/05. doi: 10.1016/j.jconrel.2016.10.007. PubMed PMID: 27744037.
  • Kotopoulis S, Dimcevski G, Gilja OH, Hoem D, Postema M. Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys. 2013;40(7):072902. Epub 2013/ 07/05. doi: 10.1118/1.4808149. PubMed PMID: 23822453.
  • Qin J, Wang TY, Willmann JK Sonoporation: applications for Cancer Therapy. Adv Exp Med Biol. 2016;880:263–291. Epub 2015/ 10/22. doi: 10.1007/978-3-319-22536-4_15. PubMed PMID: 26486343.
  • Shpak O, Verweij M, de Jong N, Versluis M. Droplets, bubbles and ultrasound interactions. Adv Exp Med Biol. 2016;880:157–174. Epub 2015/ 10/22. doi: 10.1007/978-3-319-22536-4_9. PubMed PMID: 26486337.
  • Eisenbrey JR, Merton DA, Marshall A, Liu JB, Fox TB, Sridharan A, Forsberg F. Comparison of photoacoustically derived hemoglobin and oxygenation measurements with contrast-enhanced ultrasound estimated vascularity and immunohistochemical staining in a breast cancer model. Ultrason Imaging. 2015;37(1):42–52. Epub 2014/ 03/22. doi: 10.1177/0161734614527435. PubMed PMID: 24652195.
  • Robertson RT, Levine ST, Haynes SM, Gutierrez P, Baratta JL, Tan Z, Longmuir KJ. Use of labeled tomato lectin for imaging vasculature structures. Histochem Cell Biol. 2015;143(2):225–234. Epub 2014/ 12/24. doi: 10.1007/s00418-014-1301-3. PubMed PMID: 25534591.
  • Loveless ME, Li X, Huamani J, Lyshchik A, Dawant B, Hallahan D, Gore JC, Yankeelov TE. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography. J Ultrasound Med. 2008;27(12):1699–1709. Epub 2008/ 11/22. doi: 10.7863/jum.2008.27.12.1699. PubMed PMID: 19022995; PMCID: PMC2649799.
  • Forsberg F, Stanczak M, Lyshchik A, Loren D, O’Kane P, Siddiqui A, Kowalski TE, Miller C, Fox T, Liu JB, et al. Subharmonic and endoscopic contrast imaging of pancreatic masses: a pilot study. J Ultrasound Med. 2018;37(1):123–129. Epub 2017/ 07/07. doi: 10.1002/jum.14310. PubMed PMID: 28681437; PMCID: PMC5752617.
  • Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents: basic principles. Eur J Radiol. 1998;27(Suppl 2):S157–60. Epub 1998/ 07/04. doi: 10.1016/s0720-048x(98)00057-6. PubMed PMID: 9652516.
  • Palekar-Shanbhag P, Chogale MM, Jog SV, Gaikwad SS. Microbubbles and their applications in pharmaceutical targeting. Curr Drug Deliv. 2013;10(4):363–373. Epub 2013/ 01/31. doi: 10.2174/1567201811310040001. PubMed PMID: 23360247.
  • Li J, Tang J, Li Y, Yu J, Zhang B, Yu C. Pharmacokinetic profile of paclitaxel in the plasma, lung, and diaphragm following intravenous or intrapleural administration in rats. Thorac Cancer. 2015;6(1):43–48. Epub 2015/ 08/15. doi: 10.1111/1759-7714.12139. PubMed PMID: 26273334; PMCID: PMC4448465.
  • Li D, Hu B, Zhou Y, Wan T, Si X. Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. BMC Cancer. 2018;18(1):985. Epub 2018/ 10/18. doi: 10.1186/s12885-018-4901-9. PubMed PMID: 30326871; PMCID: PMC6192226.
  • Zhan W, Gedroyc W, Xu XY. The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images. PLoS One. 2017;12(2):e0172276. Epub 2017/ 02/18. doi: 10.1371/journal.pone.0172276. PubMed PMID: 28212385; PMCID: PMC5315397.
  • Pishvaian MJ, Blais EM, Brody JR, Lyons E, DeArbeloa P, Hendifar A, Mikhail S, Chung V, Sahai V, Sohal DPS, et al. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the know your tumor registry trial. Lancet Oncol. 2020;21(4):508–518. Epub 2020/ 03/07. doi: 10.1016/S1470-2045(20)30074-7. PubMed PMID: 32135080.
  • Pishvaian MJ, Brody JR Therapeutic Implications of molecular subtyping for pancreatic cancer. Oncology (Williston Park). 2017;31(3):159–66, 68. Epub 2017/ 03/17. PubMed PMID: 28299752.
  • Zarei M, Lal S, Parker SJ, Nevler A, Vaziri-Gohar A, Dukleska K, Mambelli-Lisboa NC, Moffat C, Blanco FF, Chand SN, et al. Posttranscriptional Upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells. Cancer Res. 2017;77(16):4460–4471. Epub 2017/ 06/28. doi: 10.1158/0008-5472.CAN-17-0015. PubMed PMID: 28652247.
  • Blanco FF, Jimbo M, Wulfkuhle J, Gallagher I, Deng J, Enyenihi L, Meisner-Kober N, Londin E, Rigoutsos I, Sawicki JA, et al. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene. 2016;35(19):2529–2541. Epub 2015/ 09/22. doi: 10.1038/onc.2015.325. PubMed PMID: 26387536..
  • Hou J, Wang L. FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer. PLoS One. 2012;7(5):e36252. Epub 2012/ 05/17. doi: 10.1371/journal.pone.0036252. PubMed PMID: 22590527; PMCID: PMC3348935.
  • Morgan M, El Shaikh MA, Abu-Isa E, Davis MA, Lawrence TS. Radiosensitization by gemcitabine fixed-dose-rate infusion versus bolus injection in a pancreatic cancer model. Transl Oncol. 2008;1(1):44–49. Epub 2008/ 07/09. doi: 10.1593/tlo.07118. PubMed PMID: 18607504; PMCID: PMC2510760.
  • Krzykawska-Serda M, Agha MS, Ho JC, Ware MJ, Law JJ, Newton JM, Nguyen L, Curley SA, Corr SJ. Chemotherapy and radiofrequency-induced mild hyperthermia combined treatment of orthotopic pancreatic ductal adenocarcinoma xenografts. Transl Oncol. 2018;11(3):664–671. Epub 2018/ 04/06. doi: 10.1016/j.tranon.2018.02.023. PubMed PMID: 29621664; PMCID: PMC6054595.
  • Majumder K, Arora N, Modi S, Chugh R, Nomura A, Giri B, Dawra R, Ramakrishnan S, Banerjee S, Saluja A, et al. Novel Immunocompetent mouse model of pancreatic cancer with robust stroma: a valuable tool for preclinical evaluation of new therapies. J Gastrointest Surg. 2016;20(1):53–65. discussion Epub 2015/ 11/20. doi: 10.1007/s11605-015-2985-y. PubMed PMID: 26582596; PMCID: PMC5724755.
  • Farr N, Wang YN, D’Andrea S, Gravelle KM, Hwang JH, Lee D. Noninvasive characterization of pancreatic tumor mouse models using magnetic resonance imaging. Cancer Med. 2017;6(5):1082–1090. Epub 2017/ 04/09. doi: 10.1002/cam4.1062. PubMed PMID: 28390098; PMCID: PMC5430104.
  • Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55(17):3752–3756. Epub 1995/ 09/01. PubMed PMID: 7641188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.